Portfolio company
Conpharm AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This Swedish therapeutics company develops anti-inflammatory drugs based on semi-synthetic lignan glycosides to treat patients with rheumatoid arthritis and other inflammatory conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Transient Pharma AB
This company develops systemic peptide-based drugs for patients with inflammatory conditions, focusing on gastrointestinal disorders and acute infections.
FF Pharmaceuticals
This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.
Conveyor Therapeutics
This biotech company develops antibody drug conjugates to deliver immunosuppressive payloads for the treatment of immunological and inflammatory diseases in human patients.
LTB4 Sweden AB
The company develops leukotriene B4 based therapies to treat inflammatory conditions and infectious diseases, such as HIV, for patients with unmet medical needs.
CombinatoRx
This biopharmaceutical company develops synergistic combination medicines for healthcare providers and pharmaceutical partners to treat various diseases using a high-throughput screening platform.
Confluence Life Sciences
This biopharmaceutical company develops kinase inhibitors to treat inflammatory disorders and cancer for pharmaceutical and biotechnology industries.
Affibody AB
This biotechnology company develops biopharmaceuticals and radioligand therapies for patients with cancer and inflammatory diseases by using its proprietary protein technology platforms.
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
